Exelixis, Inc. share price logo

Exelixis, Inc. Share Price

NASDAQ: EXEL

$44.94

-1.11

(-2.41%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app

Exelixis, Inc. Stock Performance

as on April 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $44.54
    $46.65
    downward going graph

    0.89%

    Downside

    3.81%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $33.76
    $49.62
    downward going graph

    24.89%

    Downside

    10.41%

    Upside

    downward going graph

Exelixis, Inc. share price movements today

Previous Close
$46.05
Open
$46.29
Volume
1.7M
Day's Low - High
$44.54 - $46.65
52 Week Low - High
$33.76 - $49.62

Exelixis, Inc. Historical Returns

1 Month Return
+ 7.63 %
3 Month Return
+ 4.02 %
1 Year Return
+ 23.03 %
3 Year Return
+ 144.3 %
5 Year Return
+ 86.21 %

Exelixis, Inc. Stock Fundamentals & Key Indicators

Check Exelixis, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Exelixis, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Exelixis, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Exelixis, Inc. image
Exelixis, Inc.
BUY$-86.21%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$-129.51%NA0.00%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$-99.68%NA0.00%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$-NANA0.00%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$-56.77%NA0.00%

Stock Returns calculator for Exelixis, Inc. Stock including INR - Dollar returns

The Exelixis, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Exelixis, Inc. investment value today

Current value as on today

₹1,32,487

Returns

₹32,487

(+32.49%)

Returns from Exelixis, Inc. Stock

₹20,064 (+20.06%)

Dollar Impact

₹12,423 (+12.42%)

Analyst Recommendation on Exelixis, Inc. Stock

Based on 26 analysts

BUY

76.92%

Buy

19.23%

Hold

3.85%

Sell

Based on 26 analysts, 76.92% of analysts recommend a 'BUY' rating for Exelixis, Inc.. Average target price of $46.89

Exelixis, Inc. Share Price Target

Get share price movements and forecasts by analysts on Exelixis, Inc..

What analysts predicted

4.16%UPSIDE

Target Price

$46.89

Current Price

$44.94

Analyzed by

26 Analysts

Target

$46.89

Exelixis, Inc. target price $46.89, a slight upside of 4.16% compared to current price of $44.94. According to 26 analysts rating.

Exelixis, Inc. Stock’s Investor Sentiment and Interest

Search interest for Exelixis, Inc. Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:41% versus previous 30 day period

Exelixis, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
471
479
425
637
539
566
555
568
597
598
Gross Profit
453
457
403
619
522
546
536
548
579
572
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
1
85
37
226
117
139
159
184
193
244
Net Profit Margin
0.22%
17.83%
8.78%
35.49%
21.87%
24.68%
28.74%
32.53%
32.38%
40.85%

Exelixis, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Jan 2020
Dec 2020
Jan 2021
Dec 2021
Jan 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
967
967
987
987
1,434
1,434
1,611
1,830
2,168
2,320
Gross Profit
934
-
951
-
1,382
-
1,553
1,757
2,092
2,236
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
321
321
111
111
231
231
182
207
521
782
Net Profit Margin
33.17%
33.17%
11.32%
11.32%
16.10%
16.10%
11.31%
11.35%
24.04%
33.73%

Global Institutional Holdings in Exelixis, Inc.

Funds
Holdings
Vanguard Group Inc
10.04%
State Street Corp
4.38%
Geode Capital Management, LLC
2.96%
Amvescap Plc.
2.35%
Qube Research & Technologies
1.13%
See all

Exelixis, Inc. News & Key Events

  • img

    Today's Timeline - 20 October

    Mon, 12:00 PM

    -

    Exelixis announces detailed results from STELLAR-303 trial, showing zanzalintinib improves overall survival to 10.9 months versus regorafenib.

    Mon, 08:18 PM

    -

    Exelixis stock drops 12.17% after sharing detailed results from STELLAR-303 trial, despite positive overall survival findings.

Insights on Exelixis, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EXEL stock has moved up by 2.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 555.44M → 598.66M (in $), with an average increase of 2.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EXEL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 6 quarters, 117.97M → 244.52M (in $), with an average increase of 13.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 27.1% return, outperforming this stock by 4.1%

About Exelixis, Inc.

Exelixis, Inc. is an oncology company. The Company has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. It is also advancing and evolving its product pipeline portfolio, including its lead investigational asset, zanzalintinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma, for previously treated hepatocellular carcinoma and for previously treated, radioactive iodine-refractory differentiated thyroid cancer, and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer. The Company's other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved the treatment of hypertension in Japan.
OrganisationExelixis, Inc.
E-voting on sharesClick here to vote

FAQs

What is Exelixis, Inc. share price today?

Exelixis, Inc. share price today is $44.94 as on at the close of the market. Exelixis, Inc. share today touched a day high of $46.65 and a low of $44.54.

What is the 52 week high and 52 week low for Exelixis, Inc. share?

Exelixis, Inc. share touched a 52 week high of $49.62 on and a 52 week low of $33.76 on . Exelixis, Inc. stock price today i.e. is closed at $44.94,which is 9.43% down from its 52 week high and 33.14% up from its 52 week low.

How to invest in Exelixis, Inc. Stock (EXEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Exelixis, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Exelixis, Inc. Shares that will get you 0.0334 shares as per Exelixis, Inc. share price of $44.94 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Exelixis, Inc. Stock (EXEL) from India?

Indian investors can start investing in Exelixis, Inc. (EXEL) shares with as little as ₹94.22 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.20 in Exelixis, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Exelixis, Inc. share’s latest price of $44.94 as on April 25, 2026 at 1:29 am IST, you will get 0.2225 shares of Exelixis, Inc.. Learn more about fractional shares .

What are the returns that Exelixis, Inc. has given to Indian investors in the last 5 years?

Exelixis, Inc. stock has given 86.21% share price returns and 25.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?